Humana Inc. (NYSE:HUM) Shares Sold by Ieq Capital LLC

Ieq Capital LLC trimmed its position in Humana Inc. (NYSE:HUM) by 10.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,530 shares of the insurance provider’s stock after selling 640 shares during the quarter. Ieq Capital LLC’s holdings in Humana were worth $1,403,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. AMF Tjanstepension AB lifted its holdings in Humana by 166.8% during the 3rd quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock worth $12,686,000 after buying an additional 25,041 shares during the last quarter. Assenagon Asset Management S.A. raised its position in shares of Humana by 12.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,090 shares of the insurance provider’s stock worth $1,295,000 after acquiring an additional 461 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Humana by 11.1% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,528 shares of the insurance provider’s stock worth $5,282,000 after purchasing an additional 1,655 shares during the last quarter. Forsta AP Fonden boosted its holdings in Humana by 13.3% in the third quarter. Forsta AP Fonden now owns 24,700 shares of the insurance provider’s stock valued at $7,823,000 after purchasing an additional 2,900 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale increased its stake in Humana by 7.4% in the third quarter. DekaBank Deutsche Girozentrale now owns 55,702 shares of the insurance provider’s stock valued at $17,652,000 after purchasing an additional 3,862 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. TD Cowen boosted their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Truist Financial boosted their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $285.68.

Humana Price Performance

Shares of HUM opened at $255.02 on Tuesday. The firm has a market capitalization of $30.77 billion, a PE ratio of 25.63, a P/E/G ratio of 2.05 and a beta of 0.56. The stock’s 50 day moving average is $269.30 and its two-hundred day moving average is $288.93. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.39%. Humana’s payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.